Virginia Pérez‐Grijalba

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals

Noelia Fandos, Virginia Pérez‐Grijalba, Pedro Pesini et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2017 · 180 citations · Full text

Total Aβ ₄₂ /Aβ ₄₀ ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis

James D. Doecke, Virginia Pérez‐Grijalba, Noelia Fandos et al. · Neurology · 2020 · 173 citations · Full text

Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study

Virginia Pérez‐Grijalba, Judith Romero, Pedro Pesini et al. · The Journal of Prevention of Alzheimer s Disease · 2019 · 117 citations · Full text

Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial

Ana-María Lacosta, María Pascual‐Lucas, Pedro Pesini et al. · Alzheimer s Research & Therapy · 2018 · 106 citations · Full text

Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease

Rocío Pérez‐González, Consuelo Pascual, Desireé Antequera et al. · Neurobiology of Aging · 2013 · 89 citations

Phosphodiesterase 7, Alzheimer's Disease, Medicine +11